00:00So Sam obviously you know President Trump is saying this. The deals are not you know just yet in place. Is it possible that the pharma industry will have some success in pushing back on these prices.
00:14Well Vani I think the pharma industry has already had some success in the deals that have done Pfizer's deal and AstraZeneca's arrangement let's call it with the administration in terms of how they're going to manage the pricing and availability of drugs.
00:30More affordable prices for certain segments. What is as usual the case here is that there's so little detail except for those numbers that you mentioned and the drugs specifically the weight loss drugs or the obesity drugs as as we they are known.
00:49There's so little detail apart from one hundred and fifty dollars. Now let's just remember this. We have no idea what channel the president is talking about or the administration is talking about.
00:57We don't know what they've been talking about to Lilly and Nova Nordisk. Is it just for the Medicaid channel. Remember that the net price of these drugs is around five hundred and forty dollars a month at the moment.
01:11So and there are slightly cheaper versions in the vials etc. So let's just wait for the details. I think the markets decided to shoot first and then get the facts right here.
01:21It's very possible that this ends up being a sliver of the population, particularly the out of pocket patients as opposed to insurance patients, etc.
Be the first to comment